H F Fuchs1, A H Hölscher1. 1. Klinik und Poliklinik für Allgemein-, Viszeral- und Tumorchirurgie, Universitätsklinikum Köln, Deutschland.
Abstract
BACKGROUND: Therapy for oesophageal carcinoma is a subject of controversial debate. The aim of this study is to answer the question how the therapeutic decision in patients with operable, non-metastatic oesophageal cancer should be made. MATERIALS AND METHODS: A systematic literature research regarding different therapeutic strategies in patients with oesophageal cancer was undertaken. RESULTS: Multiple criteria influence the therapy for oesophageal carcinoma. Radical oesophagectomy in a multimodal setting is the therapy of choice. Definitive chemoradiation is a conservative option for high risk patients. CONCLUSION: Therapeutic decisions in patients with oesophageal cancer should only be made after standardised staging and accurate risk analysis. Georg Thieme Verlag KG Stuttgart · New York.
BACKGROUND: Therapy for oesophageal carcinoma is a subject of controversial debate. The aim of this study is to answer the question how the therapeutic decision in patients with operable, non-metastatic oesophageal cancer should be made. MATERIALS AND METHODS: A systematic literature research regarding different therapeutic strategies in patients with oesophageal cancer was undertaken. RESULTS: Multiple criteria influence the therapy for oesophageal carcinoma. Radical oesophagectomy in a multimodal setting is the therapy of choice. Definitive chemoradiation is a conservative option for high risk patients. CONCLUSION: Therapeutic decisions in patients with oesophageal cancer should only be made after standardised staging and accurate risk analysis. Georg Thieme Verlag KG Stuttgart · New York.
Authors: Hans F Fuchs; Cristina R Harnsberger; Ryan C Broderick; David C Chang; Bryan J Sandler; Garth R Jacobsen; Michael Bouvet; Santiago Horgan Journal: Surg Endosc Date: 2016-09-22 Impact factor: 4.584
Authors: Dolores T Müller; Benjamin Babic; Veronika Herbst; Florian Gebauer; Hans Schlößer; Lars Schiffmann; Seung-Hun Chon; Wolfgang Schröder; Christiane J Bruns; Hans F Fuchs Journal: Cancers (Basel) Date: 2020-11-22 Impact factor: 6.639